What Disc Medicine, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 32 | 100 |
| Total trades | 41 | 135 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 111,036 | 458,891 |
| Disposed | 173,046 | 613,638 |
| Net activity | −62,010 | −154,747 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bitterman Kevin | Director | Oct 21 | Open-market sale · S | −266 | $80.23 | −$21.3K | 12,991 |
| Bitterman Kevin | Director | Oct 21 | Open-market sale · S | −11,470 | $80.23 | −$920K | 293,430 |
| Bitterman Kevin | Director | Oct 21 | Open-market sale · S | −13,783 | $80.23 | −$1.11M | 296,277 |
| Bitterman Kevin | Director | Oct 20 | Open-market sale · S | −55 | $79.95 | −$4.4K | 13,257 |
| Bitterman Kevin | Director | Oct 20 | Open-market sale · S | −2,388 | $79.95 | −$191K | 304,900 |
| Bitterman Kevin | Director | Oct 20 | Open-market sale · S | −2,869 | $79.95 | −$229K | 310,060 |
| Bitterman Kevin | Director | Oct 19 | Open-market sale · S | −115 | $79.97 | −$9.2K | 13,312 |
| Bitterman Kevin | Director | Oct 19 | Open-market sale · S | −4,942 | $79.97 | −$395K | 307,288 |
| Bitterman Kevin | Director | Oct 19 | Open-market sale · S | −5,937 | $79.97 | −$475K | 312,929 |
| Quisel John D | Chief Executive Officer | Sep 15 | Exercise / conversion · M | +36,000 | $1.01 | +$36.4K | 262,064 |
| Bitterman Kevin | Director | Sep 11 | Open-market sale · S | −27,136 | $70.11 | −$1.9M | 0 |
| Bitterman Kevin | Director | Sep 11 | Exercise / conversion · M | +10,000 | $50.86 | +$509K | 27,136 |
| Bitterman Kevin | Director | Sep 11 | Exercise / conversion · M | +10,000 | $38.85 | +$389K | 17,136 |
| Bitterman Kevin | Director | Sep 11 | Exercise / conversion · M | +7,136 | $45.69 | +$326K | 7,136 |
| Bitterman Kevin | Director | Sep 04 | Open-market sale · S | −18 | $79.96 | −$1.44K | 13,427 |
| Bitterman Kevin | Director | Sep 04 | Open-market sale · S | −759 | $79.96 | −$60.7K | 312,230 |
| Bitterman Kevin | Director | Sep 04 | Open-market sale · S | −912 | $79.96 | −$72.9K | 318,866 |
| Bitterman Kevin | Director | Sep 03 | Open-market sale · S | −54 | $79.98 | −$4.32K | 13,445 |
| Bitterman Kevin | Director | Sep 03 | Open-market sale · S | −2,339 | $79.98 | −$187K | 312,989 |
| Bitterman Kevin | Director | Sep 03 | Open-market sale · S | −2,810 | $79.98 | −$225K | 319,778 |
Loading...